M&A TRANSACTION · 2022
Intricon Corporation acquired by Altaris Capital Partners
$236.0M· 16.8x EBITDA· 1.60x revenue
Target
Intricon Corporation
Acquirer
Altaris Capital Partners
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$144.0M
EBITDA
$14.0M
Deal Value
$236.0M
EV/EBITDA
16.8x
Context
This $236.0M acquisition of Intricon Corporation by Altaris Capital Partners sits in the medical devices sub-vertical. The 16.8x EBITDA multiple paid in 2022 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Altaris Capital Partners is acquiring as a private equity buyer; see how PE acquirers typically price medical devices businesses on our Medical Devices PE buyer-pool page.
Source
Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Intricon Corporation acquisition.